MedPath

Spinal anaesthesia comparison between plain hyperbaric drug and drug with adjuvant combination in inguinal hernia open surgery

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/10/058224
Lead Sponsor
Rajarajeswari Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. ASA I and II male patients.

2. Patients undergoing elective unilateral open inguinal hernia repair.

Exclusion Criteria

1. Patient refusal.

2. Allergy to opioids and local anesthetics.

3. Morbidly obese patients.

4. Patients with coagulation abnormalities.

5. Previous spine surgeries and spinal deformities.

6. Mentally retarded patients.

7. Infection at the site of injection.

8. Patients having neurological abnormalities.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the effect of adding 0.8mg of Nalbuphine to 0.75% hyperbaric Ropivacaine vs plain 0.75% hyperbaric Ropivacaine for unilateral inguinal hernia open mesh repair surgeries under spinal anaesthesia.Timepoint: Duration of analgesia in the first 24 hours post surgery
Secondary Outcome Measures
NameTimeMethod
To assess: <br/ ><br>Time of onset of sensory and motor blockade. <br/ ><br>Time of regression of segments of sensory blockade. <br/ ><br>Time of regression of motor blockade. <br/ ><br>Hemodynamic response. <br/ ><br>Adverse effects if any. <br/ ><br>Total analgesic consumption in 24 hours. <br/ ><br>Timepoint: Intraoperative onset of motor and sensory blockade. <br/ ><br>Intraoperative and postoperative regression of motor and sensory blockade.
© Copyright 2025. All Rights Reserved by MedPath